Starling Oncology (STLN) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 7 56 sessions, August 4, 2026 to October 21, 2026
- Largest daily move
- +28.5% close of August 7, 2026
- 1-month change
- +0% closing prices, September 21, 2026 to October 21, 2026
Company Description
Starling Oncology (NASDAQ: STLN) is classified in the medical care facilities industry within the Healthcare sector and carries a market capitalization of $696.1M.
STLN has gained 0.0% over the past month. The last closing price was $6.83.
For FY2025, Starling Oncology reported revenue of $502.7M and diluted earnings per share of -$0.54.
This page collects what Stock Titan holds for STLN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Starling Oncology (STLN) closed at $6.83 on October 21, 2026. Over the past month, the price has gained 0.0%.
STLN Metrics & Rankings
Price returns through October 21, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Starling Oncology has 4 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings. View all STLN news →
SEC Filings
Starling Oncology has filed 4 recent SEC filings, including 2 Form 8-K, 1 Form 4, 1 Form 144. The most recent filing was submitted on September 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all STLN SEC filings →
Insider Radar
Insider selling at Starling Oncology over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
Starling Oncology generated $502.7M in revenue in FY2025, and operating income reached -$36.1M (-7.2% operating margin). Diluted earnings per share stood at -$0.54. The company generated -$24.6M in operating cash flow. The current ratio was 1.59, measuring current assets divided by current liabilities.
Upcoming Events
APG Fall Presentation
Starling Oncology has 1 upcoming scheduled event. The next event, "APG Fall Presentation", is scheduled for November 19, 2026 (in 27 days). Investors can track these dates to stay informed about potential catalysts that may affect the STLN stock price.
Short Interest History
Short interest in Starling Oncology (STLN) currently stands at 6.8 million shares, down 3.7% from the previous reporting period, representing 8.1% of the float.
Days to Cover History
Days to cover for Starling Oncology (STLN) currently stands at 4.3 days, down 41.4% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since August 2026, the figure has increased by 22.8%. Across the settlements charted above, it has ranged from 3.5 to 7.3 days.
STLN Company Profile & Sector Positioning
Starling Oncology (STLN) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the NASDAQ.